IP Library Patent Application 13825606
Patent Application
App. No. 13/825,606

METAL-LIGAND COORDINATION COMPOUNDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/825,606
Abstract

The present invention relates to novel metal-ligand coordination compounds of the general formula T1-(A-T2)i, where T1 and T2 represent metal-ligand coordination compounds, to the use thereof in a device, and to a formulation and a device which comprise the novel compounds.

Claims (46)

1 - 17 . (canceled)

18 . A compound of the following formula (1)

T -( A - T 2 ) i   formula (1)

where

T 1 is an i-valent unit of the formula M 1 (L 1 ) n , and

T 2 is on each occurrence, identically or differently, a monovalent unit of the formula M 2 (L 2 ) m ;

A is a divalent unit which contains a conjugation-interrupting unit;

M 1 and M 2 are, independently of one another and identically or differently on each occurrence, selected from the group consisting of the main-group metals, transition metals, lanthanoids and actinoids;

L 1 and L 2 are, independently of one another and identically or differently on each occurrence, mono- or polydentate organic ligands, so that the units of the formulae M 1 (L 1 ) n and M 2 (L) 2 m represent metal-ligand coordination compounds;

i is an integer greater than or equal to 1;

n and m are, independently of one another, an integer greater than or equal to 2;

with the proviso that T 1 and T 2 are bonded to A via atoms of the ligands L 1 and L 2 .

19 . The compound according to claim 18 , wherein the unit L 1 -A-L 2 bridging T 1 and T 2 contains at least 10 non-hydrogen atoms.

20 . The compound according to claim 18 , wherein M 1 and M 2 are selected, independently of one another and identically or differently on each occurrence, from the group consisting of Ir, Ru, Os, Eu, Pt, Zn, Mo, W, Rh and Pd.

21 . The compound according to claim 18 , wherein A is a divalent unit selected from the group consisting of the following:

linear or branched C 1-12 -alkylene,

C 3-8 -cycloalkylene,

linear or branched mono(C 1-12 -alkyl)silylene,

linear or branched di(C 1-12 -alkyl)silylene,

linear or branched tri(C 1-12 -alkyl)silylene,

a silylene group which is substituted by one, two or three mono- or polycyclic aromatic or heteroaromatic ring systems having 5 to 60 aromatic ring atoms,

linear or branched Si1-5-silylene,

linear or branched C1-12-alkyloxy-C1-12-alkylene,

linear or branched aryl-C1-12-alkyloxy-C1-12-alkylene, where aryl is a mono- or polycyclic aromatic or heteroaromatic ring system having 5 to 60 aromatic ring atoms,

linear or branched C1-12-alkylthio-C1-12-alkylene, sulfone,

linear or branched C1-12-alkylene sulfone, sulfone oxide and

linear or branched C 1-12 -alkylene sulfone oxide,

where one or more H atoms of the said groups which represent A is optionally replaced by

F, Cl, Br, I,

a further C 1-12 -alkyl or C 3-8 -cycloalkyl, where one or more CH 2 groups of the alkyl or cycloalkyl is optionally replaced by heteroatoms, or a mono- or polycyclic aromatic or heteroaromatic ring system having 5 to 60 aromatic ring atoms, and

where one or more CH 2 groups of the said groups which represent A is optionally replaced by a divalent mono- or polycyclic aromatic or heteroaromatic ring system having 5 to 60 aromatic ring atoms, and

with the proviso that the divalent unit A can bond to the ligands L 1 or L 2 via any conceivable atom of the unit.

22 . The compound according to claim 18 , wherein i is equal to 1, 2, 3 or 4.

23 . The compound according to claim 18 , wherein n is equal to 2, 3, 4, 5 or 6.

24 . The compound according to claim 18 , wherein m is equal to 2, 3, 4, 5 or 6.

25 . The compound according to claim 18 , wherein in each case at least one L 1 and/or at least one L 2 is a bidentate ligand.

26 . The compound according to claim 18 , wherein T 1 and T 2 are phosphorescent metal-ligand coordination compounds.

27 . The compound according to claim 18 , wherein an emission band of the unit T 1 is in a wavelength range which overlaps with the wavelength range of an absorption band of the unit T 2 .

28 . The compound according to claim 18 , wherein T 2 is a dye.

29 . An electronic device comprising the compound according to claim 18 .

30 . An organic electroluminescent device containing a the compound according to claim 18 , wherein the device is an organic light-emitting diode, an organic light-emitting electrochemical cell or an organic light-emitting transistor.

31 . The organic electroluminescent device according to claim 30 , wherein the device has a planar shape and/or is in the form of a fibre.

32 . An electronic device comprising the compound according to claim 18 , wherein the device is selected from the group consisting of an organic integrated circuit, an organic field-effect transistor, an organic thin-film transistor, an organic solar cell, a dye-sensitised organic solar cell, an organic optical detector, an organic photoreceptor, an organic field-quench device, an organic laser diode and an organic plasmon emitting device.

33 . A formulation comprising at least one compound according to claim 18 and at least one solvent.

34 . The formulation according to claim 33 , wherein the formulation is a solution, dispersion or emulsion.

35 . Compound according to claim 18 or device according to claim 30 for the therapy, prophylaxis and/or diagnosis of diseases and/or cosmetic conditions.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2013
From: PAN, JUNYOU; ANEMIAN, REMI MANOUK; BUCHHOLZ, HERWIG
To: MERCK PATENT GMBH
Reel/Frame 030077/0992 →